Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

China flag China · Delayed Price · Currency is CNY
9.65
+0.15 (1.58%)
Apr 10, 2026, 12:09 PM CST
Market Cap2.88B +16.0%
Revenue (ttm)886.96M -14.9%
Net Income43.95M +79.6%
EPS0.14 +79.6%
Shares Out303.35M
PE Ratio65.56
Forward PEn/a
Dividend0.04 (0.41%)
Ex-Dividend Daten/a
Volume6,972,400
Average Volume7,377,671
Open9.41
Previous Close9.50
Day's Range9.41 - 9.69
52-Week Range7.83 - 12.90
Beta0.65
RSI51.87
Earnings DateApr 3, 2026

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It also engages in the cultivation, processing, and sale of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China. [Read more]

Sector Healthcare
Founded 2002
Employees 634
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300534
Full Company Profile

Financial Performance

In 2025, SHE:300534's revenue was 886.96 million, a decrease of -14.64% compared to the previous year's 1.04 billion. Earnings were 43.95 million, an increase of 70.32%.

Financial Statements